- Last edited on February 5, 2024
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | |||
|
geri:dementia:lewy-body [on February 5, 2024] psychdb [Neuroimaging] |
geri:dementia:lewy-body [on February 5, 2024] psychdb [Neuroimaging] |
||
|---|---|---|---|
| Line 133: | Line 133: | ||
| * Different types of [[neurology:spect|brain perfusion scans (SPECT)]] can be done:[([[https://ebmh.bmj.com/content/21/2/61|Surendranathan, A. et al. (2018). Clinical imaging in dementia with Lewy bodies. Evidence-based mental health, 21(2), 61-65.]])] | * Different types of [[neurology:spect|brain perfusion scans (SPECT)]] can be done:[([[https://ebmh.bmj.com/content/21/2/61|Surendranathan, A. et al. (2018). Clinical imaging in dementia with Lewy bodies. Evidence-based mental health, 21(2), 61-65.]])] | ||
| * **<sup>123</sup>Iodine-metaiodobenzylguanidine myocardial scintigraphy (MIBG)** may show low striatal dopamine transporter uptake | * **<sup>123</sup>Iodine-metaiodobenzylguanidine myocardial scintigraphy (MIBG)** may show low striatal dopamine transporter uptake | ||
| - | * **<sup>123</sup>I-ioflupane single-photon emission computed tomography (SPECT)** or dopamine transporter (DAT) scans | + | * **<sup>123</sup>I-ioflupane single-photon emission computed tomography (SPECT)**, also known as a **dopamine transporter (DAT) scan** |
| * This assesses DAT uptake in the basal ganglia in vivo, and has been shown to be more specific than clinical diagnostic criteria for DLB. | * This assesses DAT uptake in the basal ganglia in vivo, and has been shown to be more specific than clinical diagnostic criteria for DLB. | ||
| * It maybe the most reliable imaging modality of choice in differentiating DLB from pure AD. | * It maybe the most reliable imaging modality of choice in differentiating DLB from pure AD. | ||